MedPath

Ginsenoside Improve Metabolic Syndrome

Not Applicable
Conditions
Metabolic Syndrome
Interventions
Dietary Supplement: Ginsenoside
Dietary Supplement: Dietary fiber fill
Registration Number
NCT02034136
Lead Sponsor
CHA University
Brief Summary

Aim : Investigated the effects of Korean red ginseng supplementation on metabolic parameters such as cholesterol, blood pressure and glucose.

Randomized Control Trial.

Detailed Description

Methods : A randomized, double-blind, placebo-controlled, single-center study in 60 subjects who are not taking drugs that could affect metabolic and vascular function. Subjects will be randomized into a Korean red ginseng (3.0g/d) group or placebo group for a 4-week study.

We will collect anthropometric measurements, blood for laboratory testing, inflammatory marker, hormones and mitochondrial DNA copy number.

Subject : Older than 40 years of age, presented with metabolic syndrome. Subjects were excluded if they were taking drugs that could affect metabolic and vascular function, including BP control drug, anti-diabetic drugs and lipid-lowering drugs.

Measurement : We will collect anthropometric measurements and blood for laboratory testing at the initial(week 0) and final (week 4)visits. Serum levels of blood glucose, insulin, total cholesterol, HDL-cholesterol,triglyceride, and DNA copy number of mitochondria.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • metabolic syndrome
Exclusion Criteria
  • Taking drug for lipid-lowering, BP control and anti-diabetic.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
GinsenosideGinsenosideGinsenoside : Intervention : ginsenoside, 3 gram / day, for 28 days in intervention group
Dietary fiber fillDietary fiber fillDietary fiber fill manufactured to mimic Ginsenoside tablet
Primary Outcome Measures
NameTimeMethod
Change from baseline in metabolic syndrome profile at week 4Baseline and 4 weeks from intake of Ginsenoside

Total cholesterol, HDL-Cholesterol, Glucose, Blood Pressure, Body weight

Secondary Outcome Measures
NameTimeMethod
Change from baseline in hormones at week 4.Initial and 4 weeks later

insulin ,cortisol, testosterone, somatomedin-c and DHEAS

Trial Locations

Locations (1)

Bundang CHA Hospital

🇰🇷

Seoul, Kyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath